生物科技公司Adaptive Biotechnologies（ADPT）今日盘中股价大涨6.01%，引发市场关注。
消息面上，多家知名券商上调了Adaptive Biotechnologies的目标价。其中，TD Cowen将该公司的目标价从18美元上调至22美元，上调幅度达22%。同时，摩根大通也将目标价从17美元上调至20美元，上调幅度为17.6%。
分析师的积极态度表明他们对Adaptive Biotechnologies的未来发展前景持乐观看法，这可能是推动该公司股价上涨的主要原因。投资者似乎对这些目标价上调做出了积极回应，导致公司股价在盘中出现大幅上涨。然而，投资者在做出投资决策时仍需谨慎，并密切关注公司的后续发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.